As of Oct 8, 2026 close
- Market cap
- $3.13B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $53.89$91.53
- Volume (live)
- -
- Avg. volume (3M)
- 731.32K
Tarsus Pharmaceuticals (TARS) Stock Price & Financial Analysis
Tarsus Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $70.80 - $74.52 |
|---|---|
| 52-Week High | $91.53 |
| 52-Week Low | $53.89 |
| Open | $73.07 |
| Volume (last close) | 642.11K |
| Average Volume (3M) | 731.32K |
| Market Cap | 3.13B |
|---|---|
| Shares Outstanding | 43.39M |
| Price to Sales (P/S) | 5.17 |
| Price to Book (P/B) | 9.04 |
| EV/EBITDA | -90.70 |
| Revenue (TTM) | 606.33M |
|---|---|
| Net Income (TTM) | -46.48M |
| Free Cash Flow (TTM) | 61.55M |
| EPS (TTM) | $-1.08 |
| Profit Margin | -7.67% |
| Operating Margin | -8.00% |
| Return on Equity (ROE) | -13.40% |
| Debt to Equity | 0.21 |
| 50-Day MA | $73.59 |
|---|---|
| 200-Day MA | $68.44 |
| 1-Year Change | +2.61% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Tarsus Pharmaceuticals at a Glance
Tarsus Pharmaceuticals (TARS) has a market capitalization of $3.13B. The stock trades at 5.2× sales. Over the trailing twelve months it lost $46.48M on revenue of $606.33M and generated $61.55M of free cash flow. Revenue grew 105.2% year over year.
It holds $204.59M in cash and securities against $72.76M of debt, a net cash position of $131.83M.
Tarsus Pharmaceuticals does not currently pay a dividend.
The share price is up 2.6% over the past year. At $72.22 it sits within its 52-week range of $53.89 to $91.53, above its 200-day moving average of $68.44.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $101.50, 40.5% above the latest close.
Frequently Asked Questions About Tarsus Pharmaceuticals
What is the current stock price for TARS?
As of the Oct 8, 2026 close, TARS stock trades at $72.22. The 52-week range is $53.89–$91.53, with a day range of $70.80–$74.52.
What is the P/E ratio for TARS?
The P/E ratio (Price-to-Earnings) for TARS is shown in the Key Statistics section. This valuation metric helps compare Tarsus Pharmaceuticals, Inc. to industry peers.
Does TARS pay dividends?
Tarsus Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TARS?
Based on 9 analysts, the consensus for TARS is Buy.
What is the market cap of TARS?
Tarsus Pharmaceuticals's market capitalization is $3.13B, classifying it as a mid-cap company. Tarsus Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.